30 results on '"Amir, Achiya Z."'
Search Results
2. Elevated liver enzymes of newly diagnosed pediatric celiac patients—a prospective-observational study
3. The Yield of Routine Tissue Sampling in Pediatric Gastrointestinal Endoscopy
4. Acute pancreatitis in children with inflammatory bowel disease: Risk factors, clinical course, and prognosis
5. Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing Cholangitis
6. A recurrent, homozygous EMC10 frameshift variant is associated with a syndrome of developmental delay with variable seizures and dysmorphic features
7. Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course
8. Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (PSC‐IBD): A matched analysis from the Paediatric PSC Consortium.
9. Severe early-onset Wilson disease caused by a common pathogenic variant in the Bukharan Jewish population in Israel
10. De Novo Allergy and Immune-Mediated Disorders Following Solid-Organ Transplantation—Prevalence, Natural History, and Risk Factors
11. Assessing the Validity of Adult-derived Prognostic Models for Primary Sclerosing Cholangitis Outcomes in Children
12. Young Age Predicts Acute Pancreatitis Severity in Children
13. Bacterial resistance to commonly prescribed antibiotics was rare among children hospitalised for clinical dysentery
14. Elevated liver enzymes of newly diagnosed pediatric celiac patients—a prospective-observational study
15. The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts
16. 422 ORAL VANCOMYCIN THERAPY IS ASSOCIATED WITH IBD CLINICAL REMISSION IN PEDIATRIC PSC-IBD
17. Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis
18. The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children
19. Primary antibiotic prophylaxis in biliary atresia did not demonstrate decreased infection rate: Multi‐centre retrospective study.
20. The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children.
21. A recurrent, homozygous EMC10frameshift variant is associated with a syndrome of developmental delay with variable seizures and dysmorphic features
22. The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration
23. A Comparison of Primary Sclerosing Cholangitis with and Without Associated Inflammatory Bowel Disease: Data from the Pediatric PSC Consortium
24. Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation in Children: Data from the Pediatric PSC Consortium
25. Liver transplantation for children with acute liver failure associated with secondary hemophagocytic lymphohistiocytosis
26. Hepatoblastoma in Explanted Livers of Patients With Biliary Atresia
27. 572 - Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation in Children: Data from the Pediatric PSC Consortium
28. 423 - A Comparison of Primary Sclerosing Cholangitis with and Without Associated Inflammatory Bowel Disease: Data from the Pediatric PSC Consortium
29. The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts
30. The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.